Recombinant Protein Market Size, Share, Growth Analysis, By Product (Cytokines & Growth Factors, Antibodies), By Application (Drug Discovery & Development, Biopharmaceutical Production), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2039 | Region: Global | Published Date: November, 2024
Pages: 165 |Tables: 66 |Figures: 75

Recombinant Protein Market Insights

Global Recombinant Proteins Market size was valued at around USD 2.20 billion in 2022 and is expected to rise from USD 2.36 billion in 2023 to reach a value of USD 4.11 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).

The global recombinant protein market size is projected to rise at a high CAGR between 2023 and 2030. The genetic level of recombinant proteins proceeds with the isolation of coding sequence for the target protein and its cloning into an expression plasmid vector. The majority of therapeutic recombinant proteins are produced in microbes, yeast, or animal cells in culture. Studying protein-protein interactions requires the use of recombinant proteins. Detergents, beauty products, food supplements, food manufacturing, diagnostics, vaccinations, and therapies are just a few of the applications for these proteins.

Rise in the healthcare organizations investment in research and development activities, growing frequency of chronic illnesses, and a spike in the range of regulatory bodies ought to reduce viral infections are the primary factors towards the growth of the global recombinant protein market.

Market snapshot - 2024–2031

Global Market Size

USD 1.75 billion

Largest Segment

Hormones

Fastest Growth

hormone

Growth Rate

12% CAGR

Global Recombinant Protein Market($ Bn)
Country Share for North America (%)

To get more reports on the above market click here to Buy The Report

Recombinant Protein Market Segmental Analysis

Global Recombinant Proteins Market is segmented by Product, Application, Host cell, End User and region. Based on Product, the market is segmented into Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Proteins, Hormones, Others.  Based on Application, the market is segmented into Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Biopharmaceutical Production, Research (Academic Research, Biotechnology Research), Diagnostics, and Others. Based on Host cell, the market is segmented into Mammalian Systems, Insect Cells, Yeast & Fungi, Bacterial Cells, and Others. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical, Academic Research Institutes, Contract Research Organizations, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Analysis by Product Type 

In 2022, among the following segment growth factors and enzymes segment due to its use in a variety of research domains accounted for the highest overall market share and is expected to expand at the highest rate during the forecast period. Chemotaxis, neurology, wound repair, immunotherapy, transplantation, apoptosis, oncology, aids, COVID-19, cell culture, and stem cell research are responsible for a substantial component of the growth factors and enzymes industry.

Analysis by Application 

In terms of revenue, therapeutic accounted for a significant share in 2022 and it is expected to grow during the forecast period. Products containing recombinant proteins are used to treat various ailments like hyperglycemia, lymphoma, and inflammatory disorders. The segment is expected to maintain its dominance throughout the forecast period owing to the need for innovative therapeutic approach which is projected to rise as the incidence of diseases is growing.

Global Recombinant Protein MarketBY Type

To get detailed analysis on other segments, Request For Free Sample Report

Recombinant Protein Market Regional Insights

In 2022, North America accounted for the largest share of the global market, and this trend is expected to continue during the forecast. The rising prevalence of chronic diseases, growing R&D investments, increased research and government incentives, and the presence of manufacturing companies in the U.S. are all factors contributing to North America’s market development. 

Due to an increase in purchasing power of Asian countries, as well as research and investment, it has a significant market opportunity for further development. Numerous government policies in various nations have exerted an influence on the market in the forecast period.

Global Recombinant Protein Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Recombinant Protein Market Dynamics

Driver

Increasing demand for Biopharmaceuticals and R&D investment to fuel the recombinant protein market.

  • The market has seen a consistent increase in R&D expenditure and funding in pharmaceutical and biotechnological firms throughout the period. The number of regulatory requirements has increased dramatically in recent years, expanding a lot of choices to those with unusual illnesses like hemophilia and other bleeding disorders. 
  • The growing demand for biopharmaceuticals comprising recombinant proteins is growing due to their high potency, specificity, and lower side effects as compared with traditional small molecule drugs. Following, as a result, recombinant protein drugs are developed for a wide range of diseases including autoimmune disorders, infectious diseases, and cancer.

Restraint 

Decreasing cost of recombinant protein and lack of professionals to limit the market growth.

  • When a large number of key players enter a limited market and offer comparative products, price competition occurs. In these conditions, the cost of such items appears to be gradually lowering, limiting the expansion of the recombinant protein market. 
  • The shortage of trained medical specialists in the field of recombinant proteins also stifles industrial progress.

Request Free Customization of this report to help us to meet your business objectives.

Recombinant Protein Market Competitive Landscape

There are several dominant players in the recombinant protein business. Several strategic activities, such as mergers, partnerships, alliances, new product launches, acquisitions, and collaborations, are being implemented by the firms to help them increase their international competitiveness. For instance, in February 2021, In order to determine the best antigen dosages for the Phase 3 evaluation of its adjuvanted recombinant protein COVID-19 vaccine candidates, Sanofi and GSK have begun a new Phase 2b trial with 720 individuals who are 18 years old & older.

Recombinant Protein Market Top Players Company Profiles 

  • Bio-Techne (US) 
  • Thermo Fisher Scientific Inc. (US) 
  • Merck KGaA (Germany) 
  • Danaher Corporation (US) 
  • Abnova Corporation (Taiwan) 
  • BioLegend Inc (US) 
  • Bio-Rad Laboratories, Inc. (US) 
  • BPS Bioscience, Inc. (US) 
  • Enzo Biochem Inc. (US) 
  • GenScript (China) 
  • Miltenyi Biotec B.V. & Co. KG (Germany) 
  • Proteintech Group, Inc. (US) 
  • Sino Biological Inc. (China) 
  • ACROBiosystems Group (US) 
  • Aviva Systems Biology Corporation (US) 
  • Sartorius CellGenix GmbH (Germany) 
  • Icosagen (US) 
  • Neuromics (US) 
  • ProSpec-Tany TechnoGene Ltd. (Israel) 
  • ProteoGenix S.A.S (France)

Recombinant Protein Market Recent Development

  • In September 2021, Aviva Systems Biology, a global key player in producing antibodies, ELISA tests kits, and recombinant proteins for scientific research, confirmed the introduction of its new protein on demand semi-custom recombinant protein portfolio for basic research and pre-clinical investigations.

Recombinant Protein Key Market Trends

  • Over the projected time frame, the antibody segment is projected to expand at an exponential rate. This process has attracted attention in recent years and several businesses have embraced it for use in a variety of applications. After a selection procedure for antibodies with the necessary qualities, the genes can be introduced into an expression system, and the antibodies can be generated in large amounts.

Recombinant Protein Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to the global recombinant protein market report analysis, the growth factors and Enzymes market has the largest revenue share in 2022. The Therapeutics application has dominated the market with a market share for 2022. Region-wise, the North American region accounted for the highest market share in 2022.

Report Metric Details
Market size value in 2022 USD 2.20 billion
Market size value in 2031 USD 4.11 billion
Growth Rate 7.2%
Base year 2023
Forecast period 2024–2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Proteins, Hormones, Others
  • Application
    • Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Biopharmaceutical Production, Research (Academic Research, Biotechnology Research), Diagnostics, and Others
  • Host cell
    • Mammalian Systems, Insect Cells, Yeast & Fungi, Bacterial Cells, and Others
  • End User
    • Pharmaceutical & Biopharmaceutical, Academic Research Institutes, Contract Research Organizations, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Bio-Techne (US) 
  • Thermo Fisher Scientific Inc. (US) 
  • Merck KGaA (Germany) 
  • Danaher Corporation (US) 
  • Abnova Corporation (Taiwan) 
  • BioLegend Inc (US) 
  • Bio-Rad Laboratories, Inc. (US) 
  • BPS Bioscience, Inc. (US) 
  • Enzo Biochem Inc. (US) 
  • GenScript (China) 
  • Miltenyi Biotec B.V. & Co. KG (Germany) 
  • Proteintech Group, Inc. (US) 
  • Sino Biological Inc. (China) 
  • ACROBiosystems Group (US) 
  • Aviva Systems Biology Corporation (US) 
  • Sartorius CellGenix GmbH (Germany) 
  • Icosagen (US) 
  • Neuromics (US) 
  • ProSpec-Tany TechnoGene Ltd. (Israel) 
  • ProteoGenix S.A.S (France)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Recombinant Protein Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Recombinant Protein Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Recombinant Protein Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Recombinant Protein Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Recombinant Protein Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Recombinant Protein Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Recombinant Proteins Market size was valued at around USD 2.20 billion in 2022 and is expected to rise from USD 2.36 billion in 2023 to reach a value of USD 4.11 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).

There are several dominant players in the recombinant protein business. Several strategic activities, such as mergers, partnerships, alliances, new product launches, acquisitions, and collaborations, are being implemented by the firms to help them increase their international competitiveness. For instance, in February 2021, In order to determine the best antigen dosages for the Phase 3 evaluation of its adjuvanted recombinant protein COVID-19 vaccine candidates, Sanofi and GSK have begun a new Phase 2b trial with 720 individuals who are 18 years old & older. 'Bio-Techne (US) ', 'Thermo Fisher Scientific Inc. (US) ', 'Merck KGaA (Germany) ', 'Danaher Corporation (US) ', 'Abnova Corporation (Taiwan) ', 'BioLegend Inc (US) ', 'Bio-Rad Laboratories, Inc. (US) ', 'BPS Bioscience, Inc. (US) ', 'Enzo Biochem Inc. (US) ', 'GenScript (China) ', 'Miltenyi Biotec B.V. & Co. KG (Germany) ', 'Proteintech Group, Inc. (US) ', 'Sino Biological Inc. (China) ', 'ACROBiosystems Group (US) ', 'Aviva Systems Biology Corporation (US) ', 'Sartorius CellGenix GmbH (Germany) ', 'Icosagen (US) ', 'Neuromics (US) ', 'ProSpec-Tany TechnoGene Ltd. (Israel) ', 'ProteoGenix S.A.S (France)'

Over the projected time frame, the antibody segment is projected to expand at an exponential rate. This process has attracted attention in recent years and several businesses have embraced it for use in a variety of applications. After a selection procedure for antibodies with the necessary qualities, the genes can be introduced into an expression system, and the antibodies can be generated in large amounts.

In 2022, North America accounted for the largest share of the global market, and this trend is expected to continue during the forecast. The rising prevalence of chronic diseases, growing R&D investments, increased research and government incentives, and the presence of manufacturing companies in the U.S. are all factors contributing to North America’s market development. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Recombinant Protein Market

Report ID: SQMIG35H2039

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE